DK2913321T3 - Hidtil ukendte cannabigerolderivater - Google Patents
Hidtil ukendte cannabigerolderivater Download PDFInfo
- Publication number
- DK2913321T3 DK2913321T3 DK14156954.1T DK14156954T DK2913321T3 DK 2913321 T3 DK2913321 T3 DK 2913321T3 DK 14156954 T DK14156954 T DK 14156954T DK 2913321 T3 DK2913321 T3 DK 2913321T3
- Authority
- DK
- Denmark
- Prior art keywords
- unknown
- cannabigerol
- derivatives
- cannabigerol derivatives
- unknown cannabigerol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/24—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings
- C07C225/26—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings
- C07C225/28—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings of non-condensed quinone rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C50/00—Quinones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C50/00—Quinones
- C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
- C07C50/28—Quinones containing groups having oxygen atoms singly bound to carbon atoms with monocyclic quinoid structure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C50/00—Quinones
- C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
- C07C50/30—Quinones containing groups having oxygen atoms singly bound to carbon atoms with polycyclic non-condensed quinoid structure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C62/30—Unsaturated compounds
- C07C62/38—Unsaturated compounds containing keto groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/95—Esters of quinone carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14156954.1A EP2913321B1 (en) | 2014-02-27 | 2014-02-27 | Novel cannabigerol derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2913321T3 true DK2913321T3 (da) | 2021-10-25 |
Family
ID=50189543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14156954.1T DK2913321T3 (da) | 2014-02-27 | 2014-02-27 | Hidtil ukendte cannabigerolderivater |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9802880B2 (da) |
| EP (1) | EP2913321B1 (da) |
| JP (1) | JP6619349B2 (da) |
| KR (1) | KR102422492B1 (da) |
| CN (1) | CN106061937B (da) |
| AU (1) | AU2015222384B2 (da) |
| BR (1) | BR112016019891B1 (da) |
| CA (1) | CA2937275C (da) |
| DK (1) | DK2913321T3 (da) |
| ES (1) | ES2894760T3 (da) |
| IL (1) | IL247149B (da) |
| MX (1) | MX358084B (da) |
| RU (1) | RU2684913C2 (da) |
| WO (1) | WO2015128200A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220041538A1 (en) | 2018-12-11 | 2022-02-10 | Emerald Health Pharmaceuticals Inc | Cannabigerol quinone acid and salts thereof |
| JP2023503601A (ja) * | 2019-11-26 | 2023-01-31 | キャノピー グロウス コーポレイション | カンナビゲロール誘導体、およびカンナビノイド受容体モジュレーターとしてのその使用 |
| GR1010219B (el) * | 2021-01-22 | 2022-04-08 | Ekati Alchemy Lab Sl, | Φαρμακευτικα προϊοντα βασισμενα σε εστερες κανναβινοειδων οξεων |
| WO2023059640A1 (en) * | 2021-10-06 | 2023-04-13 | Juva Life, Inc. | Cannabigeroquinone compounds, compositions including such compounds, and uses of such compounds and compositions |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI102273B1 (fi) * | 1989-09-11 | 1998-11-13 | Eisai Co Ltd | Kinonijohdannaiset, niiden valmistaminen ja niiden farmakologinen käyttö |
| CA2570501A1 (en) * | 2004-06-18 | 2006-01-26 | Gergely Szakacs | Methods for the identification and use of compounds suitable for the treatment of drug resistant cancer cells |
| ES2657940T3 (es) * | 2010-03-26 | 2018-03-07 | Emerald Health Pharmaceuticals Inc. | Derivados de quinona de cannabinoides |
-
2014
- 2014-02-27 EP EP14156954.1A patent/EP2913321B1/en active Active
- 2014-02-27 DK DK14156954.1T patent/DK2913321T3/da active
- 2014-02-27 ES ES14156954T patent/ES2894760T3/es active Active
-
2015
- 2015-02-12 BR BR112016019891-3A patent/BR112016019891B1/pt active IP Right Grant
- 2015-02-12 RU RU2016132415A patent/RU2684913C2/ru active
- 2015-02-12 KR KR1020167025830A patent/KR102422492B1/ko active IP Right Grant
- 2015-02-12 WO PCT/EP2015/053032 patent/WO2015128200A1/en active Application Filing
- 2015-02-12 AU AU2015222384A patent/AU2015222384B2/en active Active
- 2015-02-12 JP JP2016553568A patent/JP6619349B2/ja active Active
- 2015-02-12 MX MX2016010952A patent/MX358084B/es active IP Right Grant
- 2015-02-12 US US15/122,160 patent/US9802880B2/en active Active
- 2015-02-12 CN CN201580010458.8A patent/CN106061937B/zh active Active
- 2015-02-12 CA CA2937275A patent/CA2937275C/en active Active
-
2016
- 2016-08-07 IL IL24714916A patent/IL247149B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| RU2016132415A3 (da) | 2018-09-28 |
| IL247149A0 (en) | 2016-09-29 |
| IL247149B (en) | 2019-11-28 |
| MX2016010952A (es) | 2017-02-02 |
| JP2017513810A (ja) | 2017-06-01 |
| EP2913321B1 (en) | 2021-07-21 |
| RU2684913C2 (ru) | 2019-04-16 |
| KR102422492B1 (ko) | 2022-07-19 |
| BR112016019891A2 (pt) | 2017-10-24 |
| ES2894760T3 (es) | 2022-02-15 |
| BR112016019891B1 (pt) | 2023-01-10 |
| US20170247308A1 (en) | 2017-08-31 |
| JP6619349B2 (ja) | 2019-12-11 |
| CN106061937B (zh) | 2021-07-27 |
| CA2937275C (en) | 2022-03-29 |
| AU2015222384B2 (en) | 2019-04-18 |
| RU2016132415A (ru) | 2018-04-02 |
| CN106061937A (zh) | 2016-10-26 |
| KR20160126006A (ko) | 2016-11-01 |
| WO2015128200A1 (en) | 2015-09-03 |
| CA2937275A1 (en) | 2015-09-03 |
| US9802880B2 (en) | 2017-10-31 |
| MX358084B (es) | 2018-08-03 |
| AU2015222384A1 (en) | 2016-10-06 |
| EP2913321A1 (en) | 2015-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3319956T3 (da) | Substituerede oxopyridinderivater | |
| DK3134402T3 (da) | 4-amino-imidazoquinolinforbindelser | |
| DK3204359T3 (da) | Tetrahydroisoquinolinderivater | |
| DK3119396T3 (da) | Muscarinreceptoragonister | |
| DK3201206T3 (da) | Borsyrederivater | |
| DK3006072T3 (da) | Karadgang | |
| DK3231803T3 (da) | Dihydroindolizinonderivat | |
| DE112015001664A5 (de) | Betätigungsaktuator | |
| DK3131898T3 (da) | Fluoroalkylfluorenderivativer | |
| DK3154703T3 (da) | Fuldkappe-snekkecentrifuge | |
| DK3371168T3 (da) | Indolin-2-on-derivater | |
| DK3110439T3 (da) | Pcsk9-vacciner | |
| MA41266A (fr) | Cataplasme | |
| DE112015005041A5 (de) | Gargerätevorrichtung | |
| DK3097076T3 (da) | Hidtil ukendte cyp-eicosanoidderivater | |
| ES1106784Y (es) | Secamanos | |
| DK2913321T3 (da) | Hidtil ukendte cannabigerolderivater | |
| DE102014000623A8 (de) | Halbhohlnietelement | |
| DE112015001633A5 (de) | Betätigungsaktuator | |
| DK3253769T3 (da) | Hidtil ukendte polymorfer | |
| DE112014007261A5 (de) | Messanordnung | |
| DK3091875T3 (da) | Vipbar taburet | |
| DE112017003625A5 (de) | Difluorstilben-Derivate | |
| DK3119744T3 (da) | 2-cyano-3-cyclopropyl-3-hydroxy-n-aryl-thioacrylamidderivater | |
| DE112015005055A5 (de) | Gargerätevorrichtung |